Princess Margaret Cancer Centre
AT THE PRINCESS
The immunotherapy treatments being studied and administered at The Princess Margaret are available to specific patients with
cancers for which these treatments are applicable. Many ongoing clinical trials are occurring at the Cancer Centre. Patients interested
in participating in such trials should consult their oncologist to determine if this is a suitable course of action for them.
Background imagery courtesy of Thermo Fisher Scientific. The original picture was captured by Dr. Rita Serda
ABOUT CLINICAL TRIALS:
adoptive T-cell therapy
samples of T-cells are taken out
of a patient. A lab process is
used to boost the number and
effectiveness of these cells, so
they can be put back into the
patient to attack a tumor.
MORE ON PAGE 13
The goal of
alert T-cells to the
presence of cancer
and to initiate a
strong T-cell response
against the tumor.
MORE ON PAGE 14
What is Immunotherapy?
Immunotherapy is rapidly gaining recognition
for its potential to change the way we treat cancer
and to join chemotherapy, radiation and surgery
as a fourth pillar of cancer treatment.
Within the international scientific community,
it has been long understood that the immune
system has the ability to conquer cancer.
Three types of treatments being studied, developed and tested at Princess Margaret Cancer Centre:
We’re now at a point where this knowledge has
started to become translated into treatment
possibilities for cancer patients.
We have already seen numerous success
stories of cancers fought and lives extended
The immune system has ways of
controlling its response to threats to the
body. Most of the time, it holds back
its response at various checkpoints. In
immune checkpoint blockade
are used to get the immune system
to release the brakes and allow an
MORE ON PAGE 13